Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

A young local startup offering virtual appointments for patients at risk for dementia and cognitive decline is getting ready ...

Psilera, Inc. (Psilera), a biotechnology research company specializing in the development of novel therapeutic compounds for ...

Alzamend Neuro to Present at Sequire Investor Summit; Company to Report Progress with Clinical Trials to be Initiated in 2025 and Expected Milestones ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

While celebrities might be dissolving filler, overall use it up. Dermatologists share what they suspect is happening, plus ...

From ‘Emilia Pérez’ and ‘The Brutalist’ to ‘Wicked’ and beyond, here’s how we think the 2025 Oscar nominations will shake out ...

A report questions the FDA's accelerated approval process citing Sarepta and Biogen therapies as examples. Read more here.

Researchers at the University of Kentucky (UK) are part of a groundbreaking clinical trial exploring the use of medical ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...